Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
出版年份 2019 全文链接
标题
Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
作者
关键词
-
出版物
Cancers
Volume 11, Issue 11, Pages 1704
出版商
MDPI AG
发表日期
2019-11-02
DOI
10.3390/cancers11111704
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bazedoxifene exhibits growth suppressive activity by Targeting IL-6/GP130/STAT3 Signaling in Hepatocellular Carcinoma
- (2019) Haiyan Ma et al. CANCER SCIENCE
- ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
- (2019) Mohamed I Saad et al. EMBO Molecular Medicine
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma
- (2019) Li Zhang et al. Molecular Cancer
- Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
- (2019) Dongyao Wang et al. EBioMedicine
- ADAM17: An Emerging Therapeutic Target for Lung Cancer
- (2019) Saad et al. Cancers
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Aflatoxin B 1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption
- (2018) Yu-Ju Chu et al. EUROPEAN JOURNAL OF CANCER
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
- (2018) Sven Loosen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas
- (2018) Veerabrahma Pratap Seshachalam et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Downregulation of Epstein-Barr virus-induced gene�3 is associated with poor prognosis of hepatocellular carcinoma after curative resection
- (2018) Qingjie Song et al. Oncology Letters
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages
- (2018) Tian-yi Zhou et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma
- (2018) Buyun Ma et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
- (2018) Guo Tian et al. BMJ Open
- Mutations in Craniosynostosis Patients Cause Defective Interleukin-11 Receptor Maturation and Drive Craniosynostosis-like Disease in Mice
- (2018) Maria Agthe et al. Cell Reports
- Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway
- (2017) Jiwei Zhang et al. HEPATOLOGY
- The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease
- (2017) Teng-Yu Lee et al. INTERNATIONAL JOURNAL OF CANCER
- High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma
- (2017) Yu-Yun Shao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
- (2017) Sara Torrecilla et al. JOURNAL OF HEPATOLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
- (2017) Xiao-Xiao Ding et al. Oncotarget
- Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients
- (2017) Bei-Ge Jiang et al. Oncotarget
- SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B
- (2017) Nghiem Xuan Hoan et al. Oncotarget
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73
- (2017) Hongyan Liang et al. Cancer Biomarkers
- IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice
- (2016) Juri Bergmann et al. HEPATOLOGY
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- Genetic profiling of hepatocellular carcinoma using next-generation sequencing
- (2016) Kornelius Schulze et al. JOURNAL OF HEPATOLOGY
- Latest developments in precancerous lesions of hepatocellular carcinoma
- (2016) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
- (2016) Hao Zheng et al. Scientific Reports
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7
- (2015) Jiayu Chen et al. Cancer Cell International
- LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway
- (2015) Qin Luo et al. CARCINOGENESIS
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity
- (2015) Samadhi Aparicio-Siegmund et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Mutations leading to constitutive active gp130/JAK1/STAT3 pathway
- (2015) Camilla Pilati et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
- (2015) Heike M. Hermanns CYTOKINE & GROWTH FACTOR REVIEWS
- Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
- (2015) Tsunenobu Sato et al. Hepatology International
- SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
- (2015) Xin Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A gp130–Src–YAP module links inflammation to epithelial regeneration
- (2015) Koji Taniguchi et al. NATURE
- Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
- (2015) M Hatting et al. Cell Death & Disease
- Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
- (2015) Shuqun Yang et al. Oncotarget
- Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules
- (2015) Qin Luo et al. Oncotarget
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
- (2014) Ji-hang Yuan et al. CANCER CELL
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Reconstruction of an active SOCS3-based E3 ubiquitin ligase complexin vitro: identification of the active components and JAK2 and gp130 as substrates
- (2014) Nadia J. Kershaw et al. GROWTH FACTORS
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV
- (2014) Fasiha Kanwal et al. HEPATOLOGY
- Inhibition of IL-6 family cytokines by SOCS3
- (2014) Jeffrey J. Babon et al. SEMINARS IN IMMUNOLOGY
- Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma
- (2014) Karine Poussin et al. OncoImmunology
- Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- (2013) S. Schlesinger et al. ANNALS OF ONCOLOGY
- Steatohepatitic Hepatocellular Carcinoma, a Morphologic Indicator of Associated Metabolic Risk Factors: A Study From India
- (2013) Deepali Jain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Interleukin-6 and interleukin-11: same same but different
- (2013) Christoph Garbers et al. BIOLOGICAL CHEMISTRY
- Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
- (2013) George S. Wilson et al. CANCER LETTERS
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
- (2013) Z. Kan et al. GENOME RESEARCH
- Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients
- (2013) Junji Shibahara et al. HISTOPATHOLOGY
- Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits
- (2013) Jens U. Marquardt et al. JOURNAL OF HEPATOLOGY
- SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition
- (2013) Nadia J Kershaw et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- STAT1 negatively regulates hepatocellular carcinoma cell proliferation
- (2013) GUOFU CHEN et al. ONCOLOGY REPORTS
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Mutations in the interleukin receptorIL11RAcause autosomal recessive Crouzon-like craniosynostosis
- (2013) Katharina Keupp et al. Molecular Genetics & Genomic Medicine
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Qin WANG et al. Journal of Digestive Diseases
- Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling
- (2012) Anna Dittrich et al. Molecular BioSystems
- Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth
- (2011) Pekka Nieminen et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Liver precancerous lesions and hepatocellular carcinoma: The histology report
- (2011) Massimo Roncalli et al. DIGESTIVE AND LIVER DISEASE
- Interleukin-6 signalling: More than Jaks and STATs
- (2011) René Eulenfeld et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling
- (2011) Jin-fang Zhang et al. HEPATOLOGY
- The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis
- (2011) Marcela Salomao et al. HUMAN PATHOLOGY
- A clinicopathological model to predict bone metastasis in hepatocellular carcinoma
- (2011) Zuo-Lin Xiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
- (2011) Camilla Pilati et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma
- (2011) Zuo-Lin Xiang et al. MOLECULAR BIOLOGY REPORTS
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- (2011) Daniela Ungureanu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Potential Prognostic Biomarkers for Bone Metastasis from Hepatocellular Carcinoma
- (2011) Z.-L. Xiang et al. ONCOLOGIST
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
- (2010) Guobin He et al. CANCER CELL
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array
- (2009) Yukiyasu Okamura et al. CANCER LETTERS
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
- (2009) Sara Raimondi et al. JOURNAL OF HEPATOLOGY
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
- (2009) Puneeta Tandon et al. LIVER INTERNATIONAL
- Chromosomal instability, telomere shortening and inactivation of p21WAF1/CIP1 in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis
- (2009) Yoon Hee Lee et al. MODERN PATHOLOGY
- Mutational analysis of JAK1 gene in human hepatocellular carcinoma
- (2009) H. Xie et al. NEOPLASMA
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now